Association of AKI with mortality and complications in hospitalized patients with cirrhosis.
Association of AKI with mortality and complications in hospitalized patients with cirrhosis.
复制标题
DOI:
10.1002/hep.25735
复制
发表时间:
2013-02
期刊:
影响因子:
13.5
通讯作者:
Parikh, Chirag R.
中科院分区:
文献类型:
--
作者:
Belcher, Justin M.;Garcia-Tsao, Guadalupe;Sanyal, Arun J.;Bhogal, Harjit;Lim, Joseph K.;Ansari, Naheed;Coca, Steven G.;Parikh, Chirag R.
Acute kidney injury (AKI) is a common and devastating complication in patients with cirrhosis. However, the definitions of AKI employed in studies involving patients with cirrhosis have not been standardized, lack sensitivity and are often limited to narrow clinical settings. We conducted a multi-center, prospective observational cohort study of patients with cirrhosis and AKI, drawn from multiple hospital wards, utilizing the modern acute kidney injury network (AKIN) definition and assessed for the association between AKI severity and progression with inhospital mortality. Of the 192 patients that were enrolled and included in the study, 85 (44%) patients progressed to a higher AKIN stage after initially fulfilling AKI criteria. Patients achieved a peak severity of AKIN stage 1, 26%, stage 2, 24%, and stage 3, 49%. The incidence of mortality, general medical events (bacteremia, pneumonia, urinary tract infection) and cirrhosis specific complications (ascites, encephalopathy, spontaneous bacterial peritonitis) increased with severity of AKI. Progression was significantly more common and peak AKI stage higher in non-survivors than survivors (p < 0.0001). After adjusting for baseline renal function, demographics and critical hospital and cirrhosis associated variables, progression of AKI was independently associated with mortality (adjusted OR = 3.8, 95% CI 1.3–11.1). AKI, as defined by AKIN criteria, in patients with cirrhosis is frequently progressive and severe and is independently associated with mortality in a stage-dependent fashion. Methods for earlier diagnosis of AKI and its progression may result in improved outcomes by facilitating targeted and timely treatment of AKI.
登录
查看更多内容
影响因子:
13.5
作者:
Cárdenas, A;Ginès, P;Rodes, J
通讯作者:
Rodes, J
影响因子:
38.9
作者:
du Cheyron, D;Bouchet, B;Charbonneau, P
通讯作者:
Charbonneau, P
影响因子:
29.4
作者:
Stadlbauer, Vanessa P.;Wright, Gavin A. K.;Jalan, Rajiv
通讯作者:
Jalan, Rajiv
影响因子:
3.1
作者:
Sansoè, G;Silvano, S;Rizzetto, M
通讯作者:
Rizzetto, M
影响因子:
38.9
作者:
Jenq, Chang-Chyi;Tsai, Ming-Hung;Yang, Chih-Wei
通讯作者:
Yang, Chih-Wei